Rhythm Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Berkeley Street, 12 Th Floor, Boston, Massachusetts

Insiders trading volume in the past year

Rhythm Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Meeker President and CEO, Director $11.1 M -$1.98 M -15.1% Mar 19, 2024
Hunter Smith Chief Financial Officer $5.16 M -$2.57 M -33.3% Mar 19, 2024
Yann Mazabraud EVP, Head of International $1.87 M -$757 K -28.8% Apr 14, 2024
Pamela J. Cramer Chief Human Resources Officer $1.84 M -$703 K -27.7% Mar 19, 2024
Jennifer Kayden Lee EVP, Head of North America $1.37 M -$2.65 M -66% Mar 20, 2024
Joseph Shulman Chief Technical Officer $826 K -$6.93 M -89.3% May 9, 2024
Linda Shapiro Manning Chief Medical Officer $563 K Feb 9, 2022
Edward T. Mathers Director $343 K Jun 21, 2024
William T. Roberts Chief Accounting Officer $279 K Mar 29, 2023
Christopher Paul German Corporate Controller & CAO $174 K -$15.4 K -8.12% Mar 20, 2024
D. W. J. Mcgirr Director $117 K Jun 21, 2024
Camille L. Bedrosian Director $117 K Jun 21, 2024
Stuart A. Arbuckle Director $117 K Jun 21, 2024
Jennifer L. Good Director $117 K Jun 21, 2024
Christophe Jean Director $117 K Jun 21, 2024
Lynn A. Tetrault Director $117 K Jun 21, 2024

Recent Insider Transactions by Companies or Individuals for Rhythm Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership